| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aspirin inhibits platelets from reprogramming breast tumor cells and promoting metastasis
|
Johnson, Kelly E.
|
|
|
3 |
2 |
p. 198-211
|
artikel
|
| 2 |
Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma
|
Mehta-Shah, Neha
|
|
|
3 |
2 |
p. 187-197
|
artikel
|
| 3 |
Classic hairy cell leukemia complicated by pancytopenia and severe infection: a report of 3 cases treated with vemurafenib
|
Shenoi, Daniel P.
|
|
|
3 |
2 |
p. 116-118
|
artikel
|
| 4 |
Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm
|
Lai, Hew Yeng
|
|
|
3 |
2 |
p. 122-131
|
artikel
|
| 5 |
Delay treatment of AL amyloidosis at relapse until symptomatic: devil is in the details
|
Sanchorawala, Vaishali
|
|
|
3 |
2 |
p. 216-218
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
3 |
2 |
p. i
|
artikel
|
| 7 |
Endothelial signaling by neutrophil-released oncostatin M enhances P-selectin–dependent inflammation and thrombosis
|
Setiadi, Hendra
|
|
|
3 |
2 |
p. 168-183
|
artikel
|
| 8 |
Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors
|
Wakamatsu, Manabu
|
|
|
3 |
2 |
p. 105-115
|
artikel
|
| 9 |
Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD
|
Socié, Gérard
|
|
|
3 |
2 |
p. 184-186
|
artikel
|
| 10 |
Management of direct factor Xa inhibitor–related major bleeding with prothrombin complex concentrate: a meta-analysis
|
Piran, Siavash
|
|
|
3 |
2 |
p. 158-167
|
artikel
|
| 11 |
Mulder DT, Mahé ER, Dowar M, et al. CapTCR-seq: hybrid capture for T-cell receptor repertoire profiling. Blood Adv. 2018;2(23):3506-3514.
|
|
|
|
3 |
2 |
p. 121
|
artikel
|
| 12 |
NCF1 (p47phox)–deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysis
|
Kuhns, Douglas B.
|
|
|
3 |
2 |
p. 136-147
|
artikel
|
| 13 |
Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy
|
Landsburg, Daniel J.
|
|
|
3 |
2 |
p. 132-135
|
artikel
|
| 14 |
Park EJ, Prajuabjinda O, Soe ZY, et al. Exosomal regulation of lymphocyte homing to the gut. Blood Adv. 2019;3(1):1-11.
|
|
|
|
3 |
2 |
p. 119
|
artikel
|
| 15 |
Tounsi WA, Madgett TE, Avent ND. Complete RHD next-generation sequencing: establishment of reference RHD alleles. Blood Adv. 2018;2(20):2713-2723.
|
|
|
|
3 |
2 |
p. 120
|
artikel
|
| 16 |
Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL
|
Hamadeh, Lina
|
|
|
3 |
2 |
p. 148-157
|
artikel
|
| 17 |
When should treatment of AL amyloidosis start at relapse? Early, to prevent organ progression
|
Palladini, Giovanni
|
|
|
3 |
2 |
p. 212-215
|
artikel
|
Tijdschrift beschrijving